Announcements

  • Banner reading Nature Awards Microbiome Accelerator

    The Accelerator will identify microbiome research with the potential to transform human health outcomes. Four carefully chosen applicants will be awarded $10,000 and gain entry to our immersive residential program that provides the training, mentorship and connections to translate groundbreaking research for maximum impact. The deadline for applications is 24 June 2024.

  • Logo

    On the second episode of our new podcast series, Associate Editor Cláudia Vilhena talks with co-authors Siyu He, Yinuo Jin and Lingting Shi about Starfysh, a computational toolbox combining spatial transcriptomics and histology data. They dig into the layers of Starfysh and its relevance for cancer research, and share the struggles of peer review and the wonders of collaborative work.

  • A yellow pill capsule with a radiation sign on its casing

    The commercial success of second-generation radiopharmaceuticals in oncology has re-ignited interest in this modality, resulting in a surge of dealmaking and increased venture financing for companies in the field.

Nature Biotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

Advertisement

Nature Careers

Science jobs

Advertisement